Security key
89357L501
Transcode Therapeutics, Inc. - Common Stock (RNAZ)
CUSIP: 89357L501
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 3,872
- Total 13F value
- $26,446
- Share change
- -10,554
- SEC-reported price per share
- $6.83
- Number of holders
- 5
- Value change
- -$127,930
- Number of buys
- 2
- Number of sells
- 3
- Shares outstanding
- 3,030,707
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
5
Top holders
5
RNAZ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Transcode Therapeutics, Inc. SEC filings
Transcode Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89357L501
Recent filing periods:
Ownership snapshot
Top reported holders of RNAZ - Transcode Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Thomas Joseph Tracy
Disclosed value leader
Anna Moore
Comparable rows
11/15
Latest evidence
31 Dec 2025
13D/G
13F
3/4/5
Lead comparable stake: 5%
4 rows are not safely comparable across share classes.
13D/G row: Thomas Joseph Tracy
Showing 1-6 of 15 holder rows.
Quick read
Thomas Joseph Tracy leads the comparable SEC ownership view at 5%.
11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Thomas Joseph Tracy's linked filing trail.
Comparable ownership
Top 5
Thomas Joseph Tracy
5%
SABBY MANAGEMENT, LLC
4.9%
Anson Funds Management LP
0.1%
GOLDMAN SACHS GROUP INC
0%
DRW Securities, LLC
0.39%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Thomas Joseph Tracy |
13D/G
|
5%
|
$13,300
35,000 shares
|
$0 | 07 Mar 2025 |
| SABBY MANAGEMENT, LLC |
13D/G
|
4.9%
|
$433,482
41,601 shares
|
$0 | 31 Dec 2025 |
| Anson Funds Management LP |
13D/G
|
0.1%
|
$9,494
27,125 shares
|
-$30,224 | 30 Jun 2025 |
| GOLDMAN SACHS GROUP INC |
13D/G
THE GOLDMAN SACHS GROUP, INC.
|
0%
|
$882
82 shares
|
-$526,307 | 30 Sep 2025 |
| DRW Securities, LLC |
13F
Company
|
0.39%
|
$125,796
11,702 shares
|
— | 30 Sep 2025 |
| CITIGROUP INC |
13F
Company
|
0.05%
|
$16,986
1,586 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
5
Shares
3,872
Rows available
5
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
7
Q4 2025 holders
5
Holder diff
-2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend